Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

It’s nothing of the kind. It is the next step following completion of all data analysis. The meeting covers what the FDA wants to see as a following trial: expanded safety, more absorption and systemic exposure information, more pharmakinetics, etc. All requirements and suggestions for the next trial design. None of this has anything to do with whether or not UPIX plans to go it alone. It does mean that any deal for OM is likely to be struck after the FDA meeting.


In other words, your post is bullshit.

More terrible news. The fda meeting is in december and ipix is pursuing a go it alone strategy for om. Hello 10 cents.